PerkinElmer’s contributions to the Novartis Africa Sickle Cell Disease program will accelerate access to sickle cell disease screening and treatment across the continent WALTHAM, Mass. – June 16, 2022 – PerkinElmer Inc. , a global leader committed to innovating for a healthier world, today

Original Source


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219